This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
The value of POCT in SMI health checks and patients with learning disabilities for the diagnosis, management and monitoring of diabetes and cardiovasc...
In this new webinar session, Doctor Nguyen explores the impact of the implementation of rapid molecular biology tests in the emergency department and the impact on patients care management within the emergency room.
Clinical and operational impact of rapid point-of-care SARS-COV-2 detection in an emergency department
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
This webinar will be chaired by Dr. Vivian Fonseca, an endocrinology, diabetes & metabolism specialist in Metairie, Louisiana, USA. He is current Chief, Endocrinology at the Tulane University School of Medicine.
How can POCT benefit healthcare professionals in diagnosing and managing diabetes and comorbidities?
Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.
The lab of the future: How COVID-19 taught us the value of transcendent laboratory service
Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.
The lab of the future: How COVID-19 taught us the value of transcendent laboratory service
The implementation of LF-LAM in patients with advanced HIV disease has showed promise as a simple, inexpensive POC platform. The webinar serves to provide insight into practical implementation of LF-LAM and demonstrate the successful integration in the South African context.
The importance of LF-LAM technology in TB diagnosis among patients with advanced HIV diagnosis
The webinar was an opportunity to share the success of HIV POC EID & VL monitoring in Mozambique and Cameroon to a larger audience and allow key stakeholders to be informed on the benefits of m-PIMA as a critical tool in reaching HIV targets.
Join this global webinar for real-world case reports on new and breakthrough infections and practical strategies being implemented in the pediatric and adult settings that help facilitate optimal care and workflow in time sensitive care settings.
COVID-19 co-infections: best practices for rapid differential diagnosis in pediatrics and adults
Diabetic kidney disease, and chronic kidney disease attributed to diabetes, occurs in 20-40% of patients with diabetes. Acute kidney injury is also one of the most significant complications associated with COVID-19. Point-of-care testing for albumin-creatinine ratio is a valuable tool for monitoring at-risk patients, especially in combination with other comorbid parameters, such as HbA1c and lipids.
ACR point-of-care testing for diabetic kidney disease
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
On the threshold of the 2021-2022 respiratory season, this timely update centers on influenza A&B, the COVID-19 pandemic and steps healthcare systems are taking to prepare for the upcoming (and uncertain) respiratory season
The unpredictable respiratory season: influenza and COVID-19
This clinical practice guideline from the American Heart Association (AHA) aims to give healthcare
providers consistent, clear, and evidence-based guidance for treating patients at risk for atherosclerotic
cardiovascular disease (ASCVD)
AHA cholesterol management guideline for healthcare practitioners
The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results.
AACC guidance on the management of point-of-care testing
This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).
ACC / AHA guideline on the primary prevention of cardiovascular disease
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.
IDSA guidelines on the diagnosis of COVID-19 molecular diagnostic testing
The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.
WHO guidelines on second-and third-line medicines and type of insulin for blood glucose control in diabetes
The most recent “Clinical practice recommendations for managing type 2 diabetes in primary care guidelines” from the International Diabetes Federation (IDF) seeks to summarise current evidence around optimal management of people with type 2 diabetes.
IDF Clinical practice recommendations for type 2 diabetes in primary care
The International Diabetes Federation (IDF) published an updated version of its flagship ‘Diabetes Atlas’ in 2019. The atlas covers evidence on the impact of diabetes worldwide, including recommendations for testing and screening.
IDF testing and screening recommendations for diabetes from the 2019 Diabetes Atlas
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.
KDIGO clinical practice guidelines for the management of blood pressure in chronic kidney disease
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
Dr. Erna Lenters-Westra, from the Department of Clinical Chemistry, Isala, Zwolle, The Nederlands, talks about HbA1c point-of-care testing, its advantages and perfomance-wise perspective.
HbA1c point-of-care testing: performance and advantages
In this Q&A article, we look at some key questions healthcare professionals may have about point-of-care testing (POCT). We cover how POCT can be of value within specific clinical fields and in clinicians’ day-to-day roles, including discussion of how POCT may contribute to faster results, greater flexibility for patients and reduced antibiotic prescribing.
Perspectives in point-of-care testing
en
Access Now
By using this site, you agree with our use of cookies.
